Alterity Therapeutics Limited (PRNAF)
PNK · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
Peers in Healthcare
Alterity Therapeutics Limited has no peer companies in this window.
Recent press releases
April 2026
PRNAF's ATH434 slows functional decline in MSA Phase 2 trial data
# 📰 What This Document Is 🔬 This document is a Form 6-K filing (an international filing required by the SEC) that serves as a press release. It communicates critical clinical data results from Alterity Therapeutics' lead drug candidate, ATH434. Essentially, Alterity presented new, detailed finding
March 2026
ALTERITY THERAPEUTICS LTD — 6-K Filing
# 🧾 What This Document Is This is a **6-K form**, which foreign companies like Australian-based Alterity use to report major events to the U.S. SEC. This specific filing contains an exhibit—a press release announcing **positive feedback from the FDA** about their drug development plan. It’s a regu
SEC filings
All filings →Insider trades
All insider trades →Alterity Therapeutics Limited has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Alterity Therapeutics Limited
All people →No officers or directors have been indexed for Alterity Therapeutics Limited.